FABRIS, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 7.457
EU - Europa 4.612
AS - Asia 3.705
SA - Sud America 360
AF - Africa 53
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 12
Totale 16.239
Nazione #
US - Stati Uniti d'America 7.360
SG - Singapore 1.401
IT - Italia 1.388
CN - Cina 985
HK - Hong Kong 785
SE - Svezia 700
DE - Germania 495
RU - Federazione Russa 332
BR - Brasile 300
NL - Olanda 238
BG - Bulgaria 201
IE - Irlanda 177
FR - Francia 174
GB - Regno Unito 158
UA - Ucraina 152
PL - Polonia 145
FI - Finlandia 144
TR - Turchia 114
IN - India 102
JP - Giappone 98
CH - Svizzera 81
AT - Austria 61
CA - Canada 52
ES - Italia 44
VN - Vietnam 42
MX - Messico 34
AU - Australia 31
IR - Iran 29
KR - Corea 29
BE - Belgio 25
AR - Argentina 19
DK - Danimarca 18
KZ - Kazakistan 18
SN - Senegal 17
ID - Indonesia 16
RO - Romania 16
PE - Perù 15
CZ - Repubblica Ceca 14
MA - Marocco 13
GR - Grecia 11
TW - Taiwan 11
EC - Ecuador 9
EU - Europa 9
NZ - Nuova Zelanda 9
ZA - Sudafrica 9
BD - Bangladesh 8
CO - Colombia 8
PK - Pakistan 8
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
IQ - Iraq 6
MK - Macedonia 6
MY - Malesia 6
RS - Serbia 6
EG - Egitto 5
UZ - Uzbekistan 5
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
SV - El Salvador 4
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BH - Bahrain 2
CL - Cile 2
CM - Camerun 2
DO - Repubblica Dominicana 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
Totale 16.237
Città #
Fairfield 909
Singapore 904
Hong Kong 766
Chandler 668
Woodbridge 628
Ashburn 598
Wilmington 461
Seattle 434
Houston 431
Ann Arbor 408
Cambridge 291
Beijing 285
Trieste 284
Princeton 259
Boardman 256
Jacksonville 221
Sofia 201
Dublin 170
Moscow 161
Columbus 157
Santa Clara 121
Warsaw 120
Hefei 107
Milan 97
Izmir 71
Helsinki 70
Rome 68
Nuremberg 66
Dearborn 63
Frankfurt am Main 62
San Diego 59
Munich 52
Venezia 50
Bern 48
Los Angeles 47
Düsseldorf 40
Tokyo 40
Rostock 39
Grafing 38
Redwood City 34
Washington 34
Shanghai 33
Vienna 33
Turin 32
The Dalles 27
Dong Ket 26
Guangzhou 24
Mumbai 24
London 23
São Paulo 23
Toronto 23
Turku 23
Brussels 22
Jinan 22
Des Moines 20
Nanjing 20
Naples 20
Bremen 18
Chicago 18
Lappeenranta 18
Dakar 17
Florence 17
Wuhan 17
Dallas 16
Madrid 16
Monfalcone 16
New York 16
Pune 16
Redmond 16
Brescia 15
Padova 15
Zurich 15
Bologna 14
Falls Church 14
Lauterbourg 14
Shenyang 14
Bari 13
Falkirk 13
Ho Chi Minh City 13
Montreal 13
Seoul 13
Amsterdam 12
Portsmouth 12
San Francisco 12
Sydney 12
Wroclaw 12
Council Bluffs 11
Istanbul 11
Palermo 11
San Jose 11
Zhengzhou 11
Andover 10
Hangzhou 10
Lima 10
Mexico City 10
Mykolayiv 10
Portici 10
Valenzano 10
Aarhus 9
Barcelona 9
Totale 10.783
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 436
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial 397
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 321
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 303
Coronary covered stents 264
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 234
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 233
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 225
Treatment of Functional Mitral Regurgitation in Heart Failure 215
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 212
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 206
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? 202
The role of clinical observation: Red flag 5-right ventricular involvement, arrhythmogenic right ventricular cardiomyopathy and associated phenotypes 189
The role of clinical observation: Red flag 1-cardiomyopathies and skeletal muscle involvement 187
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 185
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 185
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 183
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 182
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 178
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 175
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 173
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 172
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 171
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 168
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 167
Impact of patient delay in a modern real world STEMI network 165
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 160
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program 159
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 157
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 157
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study 154
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts 152
The role of clinical observation: red flag 8 - Cardiomyopathies in the first year of life and pediatric cardiomyopathies. 151
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. 145
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 143
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 139
null 135
Nonatherosclerotic Coronary Artery Narrowing 133
Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention 133
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 132
null 131
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 131
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy 126
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature 124
The evolution of cardiology: Changes, future challenges and opportunities 124
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 124
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity 123
If heart failure or cardiac arrest complicate pregnancy and delivery 122
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT) 121
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres 119
Clinical Spectrum of PRKAG2 Syndrome 117
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 115
La cardiomiopatia dilatativa non sempre è evolutiva: come evitare decisioni errate? 113
Direct cellular reprogramming: the hopes and the hurdles 112
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? 111
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 111
Insufficienza tricuspidale e indicazioni al trattamento 109
null 108
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 108
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 108
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 107
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 107
Natural history of spontaneous coronary dissections 103
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry 101
Guide extension, unmissable tool in the armamentarium of modern interventional cardiology. A comprehensive review 99
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection 99
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS 93
Thoracic pain: Clinical features 91
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 90
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 87
Effect of prehospital treatment in STEMI patients undergoing primary PCI 87
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 86
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery 85
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 85
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 85
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction 84
Supraventricular Tachycardia Causing Left Ventricular Dysfunction 83
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 82
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: Insights from the ATLANTIC trial 82
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut TAVR 81
A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the “DAPT-STEMI trial” 80
Near-infrared spectroscopy-intravascular ultrasound: Scientific basis and clinical applications 79
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study 79
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 78
Early prognostic stratification and identification of irreversibly shocked patients despite primary percutaneous coronary intervention 77
Appropriateness and surroundings: "Doing more does not mean doing better". Choosing wisely, an unfulfilled commitment? 75
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice 75
Variation in treatment strategy for NSTEMI: A complex phenomenon 75
Pathogenesis 73
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial 73
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention 73
Angiography and electrocardiography (ECG) for the assessment of coronary microvascular obstruction 72
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study 70
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial 69
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction 69
Intravascular Imaging Guidance of Left Main PCI: Nice to Have or Must Have? 68
Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation 67
Rimodellamento inverso nei pazienti con disfunzione ventricolare sinistra: predittori di miglioramento e revisione della letteratura 67
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion 66
Cardiac amyloidosis: do not forget to look for it 64
Totale 13.401
Categoria #
all - tutte 60.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 0 0 0 0 0 0 0 0 0 0 95
2020/20212.358 95 123 135 532 303 224 228 121 101 194 109 193
2021/20221.650 69 104 64 70 122 153 76 65 227 142 160 398
2022/20232.229 216 295 256 264 163 387 40 141 257 38 128 44
2023/20242.039 106 95 76 119 147 231 292 390 29 112 222 220
2024/20255.441 189 428 535 429 456 674 333 263 561 639 419 515
Totale 16.996